Upon activation, the NLRP3 inflammasome promotes the release of pro-inflammatory cytokines, such as IL-1β and IL-18, which are key mediators of the inflammatory response seen in severe COVID-19 cases (Vora et al., 2021). Here, IL1B is linked to COVID-19.